RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sam Chun Dang Pharm Co Stock

Sam Chun Dang Pharm Co Equity 2025

Sam Chun Dang Pharm Co Equity

266.11 B KRW

Ticker

000250.KQ

ISIN

KR7000250001

In 2025, Sam Chun Dang Pharm Co's equity was 266.11 B KRW, a 20.68% increase from the 220.5 B KRW equity in the previous year.

Sam Chun Dang Pharm Co Aktienanalyse

What does Sam Chun Dang Pharm Co do?

Sam Chun Dang Pharm Co Ltd is a pharmaceutical company specializing in Korean herbal medicine. It was founded in 1947 and is headquartered in Seoul, South Korea. The company has undergone a profound transformation in recent decades to meet the growing demands of the healthcare industry. Sam Chun Dang believes that natural remedies can play an important role in promoting health and well-being. Therefore, the company has focused on manufacturing medicines from natural herbs and plants. Since its inception, the company has aimed for better healthcare and improved quality of life for its customers. In recent years, Sam Chun Dang has become the market leader in the production of herbal medicine in Korea. It produces a variety of medicines, including products for treating traditional Korean ailments such as fatigue, loss of appetite, and colds. The company maintains several research centers and production facilities to ensure the preservation of its products' high quality. These centers are equipped with state-of-the-art equipment and have carefully trained personnel. Sam Chun Dang essentially produces three types of products: herbal medicine, dietary supplements, and health products. Herbal medicine is made from natural ingredients such as ginseng, horsetail, angelica, atractylodes, and many other herbs. Each product undergoes strict control and testing to ensure they meet the highest standards. Sam Chun Dang also produces dietary supplements that possess a wide range of health-promoting properties. These supplements contain vitamins, minerals, proteins, and many other nutrients. They are designed to naturally promote and strengthen the body's health. Additionally, Sam Chun Dang also offers health products such as masks and cleansing products. These products aim to help improve the health and well-being of customers. Sam Chun Dang is an innovative company that is always striving to improve its products and services. Over the years, the company has received several awards recognizing its leadership qualities and innovative products. Overall, Sam Chun Dang Pharm Co Ltd is a leading manufacturer of herbal medicine and dietary supplements with a strong commitment to health. The company has made a name for itself in recent years through its dedication and innovations in manufacturing products from natural ingredients. Sam Chun Dang remains committed to making a positive contribution to the healthcare industry while continuing to provide high-quality and innovative products. Sam Chun Dang Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sam Chun Dang Pharm Co's Equity

Sam Chun Dang Pharm Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sam Chun Dang Pharm Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sam Chun Dang Pharm Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sam Chun Dang Pharm Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sam Chun Dang Pharm Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sam Chun Dang Pharm Co stock

What is the equity of Sam Chun Dang Pharm Co this year?

Sam Chun Dang Pharm Co has equity of 266.11 B KRW this year.

What was the equity of Sam Chun Dang Pharm Co compared to the previous year?

The equity of Sam Chun Dang Pharm Co has increased/decreased by 20.68% increased compared to the previous year.

What impact does a high equity have on investors of Sam Chun Dang Pharm Co?

A high equity is advantageous for investors of Sam Chun Dang Pharm Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sam Chun Dang Pharm Co?

A low equity can be a risk for investors of Sam Chun Dang Pharm Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sam Chun Dang Pharm Co affect the company?

An increase in equity of Sam Chun Dang Pharm Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sam Chun Dang Pharm Co affect the company?

A reduction in equity of Sam Chun Dang Pharm Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sam Chun Dang Pharm Co?

Some factors that can affect the equity of Sam Chun Dang Pharm Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sam Chun Dang Pharm Co so important for investors?

The equity of Sam Chun Dang Pharm Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sam Chun Dang Pharm Co take to change the equity?

To change equity, Sam Chun Dang Pharm Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sam Chun Dang Pharm Co pay?

Over the past 12 months, Sam Chun Dang Pharm Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.12 %. For the coming 12 months, Sam Chun Dang Pharm Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Sam Chun Dang Pharm Co?

The current dividend yield of Sam Chun Dang Pharm Co is 0.12 %.

When does Sam Chun Dang Pharm Co pay dividends?

Sam Chun Dang Pharm Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Sam Chun Dang Pharm Co?

Sam Chun Dang Pharm Co paid dividends every year for the past 1 years.

What is the dividend of Sam Chun Dang Pharm Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.12 %.

In which sector is Sam Chun Dang Pharm Co located?

Sam Chun Dang Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sam Chun Dang Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sam Chun Dang Pharm Co from 4/1/2025 amounting to 200 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Sam Chun Dang Pharm Co pay the last dividend?

The last dividend was paid out on 4/1/2025.

What was the dividend of Sam Chun Dang Pharm Co in the year 2024?

In the year 2024, Sam Chun Dang Pharm Co distributed 0 KRW as dividends.

In which currency does Sam Chun Dang Pharm Co pay out the dividend?

The dividends of Sam Chun Dang Pharm Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sam Chun Dang Pharm Co

Our stock analysis for Sam Chun Dang Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sam Chun Dang Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.